Auto insurance from A to Z Auto insurance in detail and practical tips for car owners

Study in Taiwan Reveals that Acupuncture More Effective than Topiramate in Reducing Number of Migraine Headaches, the Consumer Justice Foundation Reports

(PRWEB) October 10, 2012

The Consumer Justice Foundation, a for-profit corporation whose mission is to provide the public with free online informational resources regarding the potential dangers of using certain prescription medications, hereby alerts the public to the results of a study conducted in Taiwan concerning the use of acupuncture versus topiramate by patients suffering from migraine headaches. The study concluded that the patients who were given acupuncture treatments saw a greater decrease in the number of migraine headaches suffered as well as a lower rate for adverse responses to the respective treatments. Topiramate is the active ingredient in the migraine medication known as Topamax.

The study, which was entitled, Acupuncture Versus Topiramate in Chronic Migraine Prophylaxis: A Randomized Clinical Trial that was conducted in Taiwan by Dr. Hen-Hong CHANG at the Chang Gung Memorial Hospital, broke people who suffered from regular migraine headaches into two groups: one group used topiramate to treat their migraine headaches and the other group was administered regular acupuncture treatments of 30 minutes each at twice per week over 12 weeks.

The results revealed that the acupuncture group showed a drop in the average monthly number of migraine headaches from 20.2 to 9.8 as compared to the topiramate group, which showed a drop from 19.8 to 12.0. In addition, the rate of adverse responses to the acupuncture treatments registered at 6 percent as compared to 66 percent for those who used topiramate. The study stated with regards to its conclusion that acupuncture led to a significantly larger decrease in the mean monthly number of moderate/severe headache days.

Topiramate is the active ingredient in the prescription medication known as Topamax, and Topamax is manufactured by Johnson & Johnson. It was approved for the treatment of migraine headaches in 2004 by the FDA, but the drug has been changed in terms of its pregnancy category by the FDA from C to D because of alleged links to birth defects in children whose mothers took Topamax during the early stages of pregnancy.

About the Consumer Justice Foundation

The Consumer Justice Foundation, whose Web site can be found at http://www.consumerjusticefoundation.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

Find More Auto Insurance Press Releases